Clinical Trial Update: Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab with either anastrozole or fulvestrant plus trastuzumab in postmenopausal metastatic breast cancer; study completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Bevacizumab (bevacizumab)
• Fulvestrant (fulvestrant)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Breast Cancer, Breast Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2013-02-15